Search Results - "Spiess, P.E"

A Dosimetric Study of Polyethylene Glycol Hydrogel in 200 Prostate Cancer Patients Treated With High-Dose-Rate Brachytherapy ± Intensity Modulated Radiation Therapy by Strom, T, Wilder, R.B, Fernandez, D.C, Mellon, E.A, Saini, A.S, Hunt, D.C, Pow-Sang, J.M, Spiess, P.E, Sexton, W.J, Poch, M.A, Biagioli, M.C

Get full text

Health Behaviors and Depressive Symptoms in Testicular Cancer Survivors by Shinn, E. Huh, Basen-Engquist, K, Thornton, B, Spiess, P.E, Pisters, L

“…Objectives Testicular cancer has one of the highest 5-year survival rates of all cancer sites. The survival period is marked by an increased risk of secondary…”
Get full text

Hepatic yttrium-90 radioembolization treatment of patients with liver dominant metastatic renal cell cancer - the Moffitt experience by Shah, J, Choi, J, El-Haddad, G.E, Sweeney, J, Biebel, B, Spiess, P.E, Gupta, S, Fishman, M.N, Hoffe, S.E, Shridhar, R, Kis, B

Get full text

Regression-tree analysis for identifying the best candidates to neoadjuvant chemotherapy in patients with clinical node-positive penile squamous-cell carcinoma by Bandini, M., Zhu, Y., Ye, D., Ornellas, A.A., Watkin, N., Ager, M., Hakenberg, O.W., Heidenreich, A., Raggi, D., Catanzaro, M., Haidl, F., Mazzone, E., Pederzoli, F., Marandino, L., Briganti, A., Montorsi, F., Chipollini, J., Azizi, M., Albersen, M., Brower, O.R., Spiess, P.E., Necchi, A.

Get full text

Neoadjuvant chemotherapy plus radical cystectomy versus radical cystectomy alone in clinical T2 bladder cancer patients without hydronephrosis: Results from a large multicenter cohort study by Soria, F., Black, P.C., Fairey, A.S., Cookson, M.S., Yu, E.Y., Kassouf, W., Dall’era, M.A., Sridhar, S.S., Mcgrath, J.S., Wright, J.L., Thorpe, A.C., Morgan, T.M., Daneshmand, S., Holzbeierlein, J.M., Bivalacqua, T.J., North, S., Barocas, D.A., Lotan, Y., Grivas, P., Stephenson, A.J., Shah, J.B., Van Rhijn, B.W., Spiess, P.E., Shariat, S.F., Gontero, P.

Get full text

Development of a risk calculator of recurrence in inguinal lymph-node metastatic (ILNM) patients with surgically-resected penile squamous-cell carcinoma (PSCC) by Bandini, M., Zhu, Y., Ye, D., Ornellas, A.A., Watkin, N., Ager, M., Hakenberg, O.W., Heidenreich, A., Raggi, D., Catanzaro, M., Haidl, R., Marandino, L., Pederzoli, F., Briganti, A., Montorsi, F., Chipollini, J., Azizi, M., Albersen, M., Brower, O.R., Spiess, P.E., Necchi, A.

Get full text

Nomogram predicting bladder cancer specific mortality after neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer: results of an international consortium by Mir, C., Marchioni, M., Zargar, H., Zargar-Shoshtari, K., Fairey, A.S., Mertens, L.S., Dinney, C.P., Krabbe, L., Cookson, M.S., Jacobsen, N., Griffin, J., Montgomery, J.S., Vasdev, N., Yu, E.Y., Xylinas, E., McGrath, J.S., Kassouf, W., Dell’Era, M.A., Sridhar, S.S., Aning, J., Shariat, S.F., Wright, J.L., Thorpe, A.C., Morgan, T.M., Holzbeierlein, J.M., Bivalacqua, T.J., North, S., Barocas, D.A., Lotan, Y., Grivas, P., Stephenson, A.J., Shah, J.B., van Rhijn, B.W., Spiess, P.E., Daneshmand, S., Black, P.C.

Get full text

The merits of cytology in the workup for upper tract urothelial carcinoma - a contemporary review of a perplexing issue by Sverrisson, E F, Kim, T, Espiritu, P N, Sexton, W J, Pow-Sang, J M, Dhillon, J, Spiess, P E

“…The importance of upper tract cytology for evaluating tumors is unclear. We correlated upper tract cytology with histologic findings in patients who underwent…”
Get full text

Differential expression of immunoregulatory molecules and highly-associated cancer genes may provide novel insights into strategic trial design for therapeutics by Adashek, J.J., Szeto, C.W., Reddy, S.K., Spiess, P.E.

Get full text

1235P - Differential expression of immunoregulatory molecules and highly-associated cancer genes may provide novel insights into strategic trial design for therapeutics by Adashek, J.J., Szeto, C.W., Reddy, S.K., Spiess, P.E.

“…The use of immunotherapy in multiple cancer types is becoming mainstay along with next-generation sequencing (NGS) to identify potential actionable targets. We…”
Get full text

Recovery of patient-reported QOL after cystectomy for bladder cancer by Gilbert, S., Reich, R.R., Poch, M.A., Spiess, P.E., Li, R., Sexton, W.J., Jacobsen, P.B.

Get full text

667P Cost effectiveness of immune checkpoint inhibitors in combination with targeted therapies in metastatic renal cell carcinoma by Mason, N., Kim, Y., Shah, S., Adashek, J.J., Manley, B.J., Spiess, P.E., Chahoud, J.

Get full text

690P Comprehensive genomic profiling (CGP) of VHL mutated and VHL wild type clear cell renal cell carcinoma (ccRCC) by Bratslavsky, G., Grivas, P., Spiess, P.E., Decker, B., Danziger, N.A., Sokol, E., Ross, J.S.

Get full text

Patient Reported Outcomes (PRO) in clinical trials leading to GU cancer drug approvals: A focus on the quality of data reporting and analysis by Paravathaneni, M., Vidhu, J., Safa, H., Chadha, J.S, Shah, S., Gilbert, S.M, Manley, B.J, Spiess, P.E, Youngchul, K., Chahoud, J.

Get full text

A0999 - Patient Reported Outcomes (PRO) in clinical trials leading to GU cancer drug approvals: A focus on the quality of data reporting and analysis by Paravathaneni, M., Vidhu, J., Safa, H., Chadha, J.S, Shah, S., Gilbert, S.M, Manley, B.J, Spiess, P.E, Youngchul, K., Chahoud, J.

Get full text

1778P Comparative genomic alterations (GA) landscape in urothelial carcinoma of the bladder (UCB) in patients of South Asian ancestry (SAS) by Spiess, P.E., Bratslavsky, G., Grivas, P., Jacob, J., Necchi, A., Danziger, N.A., Pavlick, D.C., Tukachinsky, H., Graf, R.P., Ross, J.S.

Get full text

1393P Comparison of genomic alterations (GA) landscape in SPOP mutated (SPOPmut) and SPOP wild type (SPOPwt) clinically advanced prostate cancer (CAPC) by Bratslavsky, G., Spiess, P.E., Grivas, P., Jacob, J., Necchi, A., Danziger, N.A., Pavlick, D.C., Tukachinsky, H., Graf, R.P., Ross, J.S.

Get full text

Urachal (U) and Non-Urachal (NU) Adenocarcinomas (adenoCA) of the bladder: A comparative Comprehensive Genomic Profiling (CGP) study by Cigliola, A., Basnet, A., Jacob, J., Bratslavsky, G., Cheng, L., Grivas, P., Kamat, A.M., Spiess, P.E., Dean, P., Lin, D.I., Ross, J.S., Necchi, A.

Get full text

A0863 - Urachal (U) and Non-Urachal (NU) Adenocarcinomas (adenoCA) of the bladder: A comparative Comprehensive Genomic Profiling (CGP) study by Cigliola, A., Basnet, A., Jacob, J., Bratslavsky, G., Cheng, L., Grivas, P., Kamat, A.M., Spiess, P.E., Dean, P., Lin, D.I., Ross, J.S., Necchi, A.

Get full text

891P Landscape of NOTCH1 genomic alterations (GA) in head and neck squamous cell carcinoma (HNSCC) and T-ALL by Ikenberg, K., Bratslavsky, G., Jacob, J., Danziger, N.A., Necchi, A., Spiess, P.E., Grivas, P., Pauli, C., Moch, H., Ross, J.S.

Get full text